Design and preliminary results of a randomized study on the conversion of treatment with calcineurin inhibitors to mycophenolate mofetil in chronic renal graft failure: effect, on serum cholesterol levels

By Suwelack B.   Gerhardt U.   Kobelt V.   Hillebrand U.   Matzkies F.   Hohage H.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1803-1805

Elsevier

Access to resources Recommend Favorite

Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

By Herrero J.I.   Quiroga J.   Sangro B.   Pardo F.   Rotellar F.   Cienfuegos J.A.   Prieto J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1877-1879

Elsevier

Access to resources Recommend Favorite

Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil

By Mange K.C.   Bloom R.D.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3119-3121

Elsevier

Access to resources Recommend Favorite

Effect of mycophenolate mofetil on progression of chronic allograft nephropathy

By Yeung S.   Lee W.   Tong K.L.   Tsang W.K.   Chan H.W.H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 176-178

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil

By Becker B.N.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2777-2778

Elsevier

Access to resources Recommend Favorite